Drugs / Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell)
Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06175494 | Dec 2023 → Jul 2024 | COVID-19 | WestVac Biopharma Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06175494 ↗ |
| Modality | Vaccine | “Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell)” NCT06175494 ↗ |